Bravado Health
Bravado Health (PRN Software, LLC; brands TreatRx, DoseSpot) provides a standalone, cloud-based ePrescribing platform — including EPCS for Schedule II-V controlled substances — targeted at US healthcare providers without EHR/EMR systems, sold via self-serve monthly subscriptions with no setup fees.
- Company typePrivate
- Founded1998
- HeadquartersWest Palm Beach, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Bravado Health does
Bravado Health (operating through its legal entity PRN Software, LLC and trade names TreatRx and DoseSpot) is a US-based healthcare IT company that provides a standalone, cloud-based electronic prescribing (ePrescribing) platform. Founded in 1998 and headquartered in West Palm Beach, Florida with operational presence in Boston, Massachusetts, the company targets physicians, prescribers, and healthcare providers — particularly those without an EHR/EMR system — who require electronic prescribing capabilities for both standard medications and Schedule II-V controlled substances. The flagship TreatRx platform is certified through Surescripts for e-prescribing network connectivity and through the Drummond Group for EPCS (Electronic Prescribing of Controlled Substances), and is HIPAA and SOC 2 Type 2 compliant.
The platform's technical architecture rests on direct integration with the Surescripts pharmacy network and with Pharmacy Benefit Managers (PBMs) for real-time eligibility and formulary data, supplemented by a curated drug reference database of 60,000+ medications and a year of nationwide medication history. Core functional capabilities include real-time prescription benefit display, drug-drug and drug-allergy interaction alerts, weight-based pediatric dosing, pharmacy-initiated refill management, formulary customization, and an SMS-delivered pharmacy cost-saving program that activates patient co-pay assistance at the point of prescribing without provider intervention. The product is accessible from any device via a web application with no installation required.
Bravado Health operates a product-led, self-serve go-to-market motion. Providers can sign up directly through the ayva.bravadohealth.com website, complete onboarding in under 24 hours, and subscribe to monthly tiers — a base ePrescribing plan and a premium upgrade that adds controlled-substance prescribing capability. The company charges no setup or integration fees and has not publicly disclosed price points. It employs 11–50 people, has raised approximately $1.33 million in disclosed funding (April 2021), serves only the US market, and has not disclosed revenue. No enterprise customer logos are named; the customer base appears to consist of distributed independent and small-practice prescribers acquired through self-serve channels.
Bravado Health firmographics
Firmographics- Name
- Bravado Health
- Legal name
- PRN Software, LLC
- Website
- https://bravadohealth.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bravado Health (PRN Software, LLC; brands TreatRx, DoseSpot) provides a standalone, cloud-based ePrescribing platform — including EPCS for Schedule II-V controlled substances — targeted at US healthcare providers without EHR/EMR systems, sold via self-serve monthly subscriptions with no setup fees.
- Ownership category
- akta.pro rank
Bravado Health industry classification
Industry- Product category
- Electronic Prescribing (ePrescribing) Software
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history) (HLALAIAD)
- akta.pro secondary industries
- Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance (HLACAKAJ), Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)
Keywords
Where Bravado Health is headquartered
LocationHeadquarters
- HQ city
- West Palm Beach
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bravado Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Subscription - Base Tier: Monthly subscription with no hidden fees providing core ePrescribing functionality including prescription benefit information and price transparency at point of prescribing. Cancel at any time.
- Subscription - Controlled Substances Upgrade: Upgrade subscription tier to include prescribing of Schedule II-V controlled substances, providing higher-tier functionality for providers who need EPCS capabilities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Base subscription with standard ePrescribing features |
| Subscription | Monthly | Premium subscription with controlled substances (EPCS) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Bravado Health product offering
Product offeringCore offering
TreatRx is Bravado Health's standalone, cloud-based electronic prescribing (ePrescribing) platform that enables U.S. healthcare providers to electronically write prescriptions for both non-controlled and Schedule II-V controlled substances without requiring EHR/EMR integration or in-house technical staff. The platform delivers real-time prescription benefit and price transparency, drug reference, formulary, clinical decision support, pharmacy-initiated refill management, and SMS-activated patient co-pay assistance directly at the point of prescribing, sold via monthly subscription tiers with an upgrade path for EPCS (controlled substance) capability.
Product overview
TreatRx is a standalone ePrescribing solution offered by Bravado Health (operated by PRN Software, LLC) that enables healthcare providers to electronically prescribe medications including Schedule II-V controlled substances. The platform integrates real-time prescription benefit information, price transparency, and pharmacy cost-saving programs directly at the point of prescribing. The core TreatRx platform is supplemented by optional add-ons for controlled substance prescribing (EPCS) and specialized modules for eligibility/formulary access, medication history, clinical decision support, prescription management, and search functionality. Pricing is offered through monthly subscription tiers with no cost integration and setup.
Differentiator
Problem solved
Functional benefit
Products and services
- TreatRx
Quantifiable outcome
- 2/3 of prescribers would likely change Rx to a drug better covered by patient's benefit plan or not requiring prior authorization
- +2 more outcomes
Companies that use Bravado Health
Customer profileSegments1 record
Ideal customer profiles1 record
Bravado Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature8 records
Bravado Health partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- SurescriptscoreSurescripts provides the network infrastructure for e-prescribing connectivity, enabling TreatRx to access pharmacy networks and transmit prescriptions electronically. TreatRx is certified through Surescripts for e-prescribing functionality.
- Drummond GroupcoreDrummond Group provides EPCS (Electronic Prescribing of Controlled Substances) certification testing services, verifying that TreatRx meets security standards for prescribing Schedule II-V controlled substances electronically.
- Pharmacy Benefit Managers (PBMs)corePBMs provide real-time eligibility and formulary data integrated into TreatRx, enabling providers to view patient coverage, alternative medications, and cost information at point of prescribing.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Bravado Health competitors and assessment
Company assessmentDirect peers
- DoseSpot: Operated by the same parent (Bravado Health / PRN Software, LLC), DoseSpot provides embedded ePrescribing for digital health platforms. It is the closest comparable product to TreatRx within the same corporate family, targeting digital-health-vendor integrations versus TreatRx's standalone prescriber positioning.
- DrFirst: DrFirst offers ePrescribing, EPCS, and medication management solutions to providers and EHR vendors. It directly competes with TreatRx in standalone and integrated ePrescribing, including certified EPCS and real-time benefit functionality.
- iPrescribe (by eHealth Solutions): iPrescribe is a standalone, mobile-first ePrescribing app with EPCS capabilities targeting independent prescribers. It competes head-to-head with TreatRx for the same small-practice, no-EHR prescriber segment.
- NewCrop: NewCrop provides electronic prescribing and medication management technology integrated into EHRs and health systems. It overlaps with TreatRx in core ePrescribing and EPCS, typically serving larger integrated customers.
Broad incumbents
- Practice Fusion: Practice Fusion is a cloud-based EHR for small and independent practices with bundled ePrescribing and EPCS. It competes indirectly with TreatRx by offering ePrescribing as part of a broader EHR suite aimed at the same small-practice customer.
- Epic Systems: Epic is the dominant enterprise EHR, with deeply embedded ePrescribing and EPCS modules used by large hospital systems and academic medical centers. As a broad incumbent, it represents the long-term competitive ceiling for standalone tools like TreatRx.
- Oracle Health (formerly Cerner): Oracle Health offers enterprise EHR platforms with integrated ePrescribing and EPCS across large health systems. It is a broad incumbent competitor whose embedded modules reduce the addressable market for standalone ePrescribing vendors.
Others
- Surescripts: Surescripts operates the nationwide ePrescribing network that TreatRx depends on for pharmacy connectivity, eligibility, and medication history. While not a direct competitor, it is a critical infrastructure provider whose terms and certifications directly shape TreatRx's economics.
- GoodRx: GoodRx is a consumer-facing prescription savings platform that overlaps with TreatRx's pharmacy cost-saving and copay assistance functionality. While not an ePrescribing competitor, it competes for the same patient affordability and adherence value proposition.
Emerging players
- Arrive Health: Arrive Health delivers real-time prescription benefit and price transparency tools integrated into EHRs and provider workflows. It competes with TreatRx's RTPB feature and is extending into prescribing workflow automation—an emerging adjacent competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Bravado Health social profiles
Digital presenceBravado Health compliance and trust
Trust signalCompliance4 records
Bravado Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bravado Health leadership team
Management profileNumber of profiles
Profiles7 records
Bravado Health funding detail
Funding detailFunding overview
Funding rounds3 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bravado Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bravado Health
What does Bravado Health do?
TreatRx is Bravado Health's standalone, cloud-based electronic prescribing (ePrescribing) platform that enables U.S. healthcare providers to electronically write prescriptions for both non-controlled and Schedule II-V controlled substances without requiring EHR/EMR integration or in-house technical staff. The platform delivers real-time prescription benefit and price transparency, drug reference, formulary, clinical decision support, pharmacy-initiated refill management, and SMS-activated patient co-pay assistance directly at the point of prescribing, sold via monthly subscription tiers with an upgrade path for EPCS (controlled substance) capability.
When was Bravado Health founded?
Bravado Health was founded in 1998. It employs 11 to 50 people.
Where is Bravado Health based?
Bravado Health is headquartered in West Palm Beach, United States, in the North America region.
How does Bravado Health make money?
Two revenue lines are on record. Subscription - Base Tier is the primary driver. The others are subscription - Controlled Substances Upgrade.
Who are Bravado Health's main competitors?
Direct peers on record are DoseSpot, DrFirst, iPrescribe (by eHealth Solutions) and NewCrop. Broad incumbents are Practice Fusion, Epic Systems and Oracle Health (formerly Cerner). Others are Surescripts and GoodRx. Arrive Health is listed as an emerging player.
Does Bravado Health have an API?
No public API is recorded for Bravado Health.
What industry is Bravado Health in?
Bravado Health's product category is Electronic Prescribing (ePrescribing) Software. Its primary akta.pro industry code is HLALAIAD, ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history), with a secondary code of HLACAKAJ, Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance. Its SIC code is 7372.